Insider · CIK 0001226491

MCEWAN ALASTAIR STUART

Reports to the SEC for 4 companies · CARY, NC

sec.gov

Transactions

Companies

Filings

CIK

0001226491

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-02-03	CORNERSTONE THERAPEUTICS INCD Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−44.2K sh	$9.50	−$420K	0
2014-02-03	CORNERSTONE THERAPEUTICS INCD Disposition to Issuer	CFO and Treasurer	DDisposition to Issuer	−272K sh	$9.50	−$2.59M	0
2013-09-15	CORNERSTONE THERAPEUTICS INCA Award	CFO and Treasurer	AAward	+19.2K sh	—	—	316,413
2012-11-06	CORNERSTONE THERAPEUTICS INCA Award	CFO and Treasurer	AAward	+50K sh	—	—	297,241
2009-06-19	CORNERSTONE THERAPEUTICS INCS Sale	CFO and Treasurer	SSale	−8,141 sh	$9.00	−$73.3K	0
2009-06-15	CORNERSTONE THERAPEUTICS INCS Sale	CFO and Treasurer	SSale	−43.3K sh	$8.51	−$369K	8,141
2009-06-12	CORNERSTONE THERAPEUTICS INCS Sale	CFO and Treasurer	SSale	−3,388 sh	$8.51	−$28.8K	51,457
2009-06-09	CORNERSTONE THERAPEUTICS INCS Sale	CFO and Treasurer	SSale	−17K sh	$8.50	−$145K	62,010
2009-06-08	CORNERSTONE THERAPEUTICS INCS Sale	CFO and Treasurer	SSale	−36.7K sh	$7.93	−$291K	79,041
2009-06-05	CORNERSTONE THERAPEUTICS INCS Sale	CFO and Treasurer	SSale	−3,300 sh	$7.50	−$24.8K	115,741
2009-05-28	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)A Award	CFO and Treasurer	AAward	+4,167 sh	—	—	4,167
2009-05-18	CORNERSTONE THERAPEUTICS INCM Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	+119K sh	$0.43	+$51.2K	119,041
2009-05-18	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−83.3K sh	—	—	0
2009-05-18	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−11.9K sh	—	—	142,849
2009-05-18	CORNERSTONE THERAPEUTICS INCOption to Purchase Common Stock (Right to Buy)M Exercise/Conversion	CFO and Treasurer	MExercise/Conversion	−23.8K sh	—	—	119,041
2007-06-01	Aptiv Solutions, Inc.Option to Purchase Common StockA Award	Director	AAward	+1.5M sh	—	—	1,500,000
2006-06-01	Aptiv Solutions, Inc.Option Grant to purchase Common StockA Award	Director	AAward	+1.5M sh	—	—	1,500,000
2006-06-01	Aptiv Solutions, Inc.Option Grant to purchase Common StockA Award	Director	AAward	+1M sh	—	—	1,000,000
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	Corporate VP	SSale	−28K sh	$47.26	−$1.32M	8,000
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.M Exercise/Conversion	Corporate VP	MExercise/Conversion	+10.7K sh	$18.35	+$196K	34,117
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.M Exercise/Conversion	Corporate VP	MExercise/Conversion	+8,000 sh	$22.19	+$178K	42,117
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.M Exercise/Conversion	Corporate VP	MExercise/Conversion	+28K sh	$29.55	+$827K	70,117
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	Corporate VP	SSale	−10.7K sh	$47.26	−$504K	59,451
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	Corporate VP	SSale	−8,000 sh	$47.26	−$378K	0
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	Corporate VP	SSale	−23.5K sh	$47.26	−$1.11M	36,000
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to buy)M Exercise/Conversion	Corporate VP	MExercise/Conversion	−10.7K sh	$18.35	−$196K	0
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to buy)M Exercise/Conversion	Corporate VP	MExercise/Conversion	−8,000 sh	$22.19	−$178K	0
2004-12-23	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to buy)M Exercise/Conversion	Corporate VP	MExercise/Conversion	−28K sh	$29.55	−$827K	0
2004-10-20	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Employee Stock Option (right to buy)A Award	Corporate VP	AAward	+28K sh	—	—	28,000
2004-10-20	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Employee Stock Option (right to buy)A Award	Corporate VP	AAward	+16K sh	—	—	16,000
2004-10-20	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	Corporate VP	AAward	+79.5K sh	—	—	79,518
2004-10-20	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Employee Stock Option (right to buy)A Award	Corporate VP	AAward	+209 sh	—	—	209
2004-10-20	INVERESK RESEARCH GROUP INCD Disposition to Issuer	Group Executive Vice President	DDisposition to Issuer	−166K sh	—	—	0
2004-10-20	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Employee Stock Option (right to buy)A Award	Corporate VP	AAward	+12K sh	—	—	12,000
2004-10-20	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Employee Stock Option (right to buy)A Award	Corporate VP	AAward	+9,390 sh	—	—	9,390
2004-10-20	INVERESK RESEARCH GROUP INCOption to Purchase Common StockD Disposition to Issuer	Group Executive Vice President	DDisposition to Issuer	−35K sh	—	—	0
2004-10-20	INVERESK RESEARCH GROUP INCOption to Purchase Common StockD Disposition to Issuer	Group Executive Vice President	DDisposition to Issuer	−15K sh	—	—	0
2004-10-20	INVERESK RESEARCH GROUP INCOption to Purchase Common StockD Disposition to Issuer	Group Executive Vice President	DDisposition to Issuer	−20K sh	—	—	0
2004-10-20	INVERESK RESEARCH GROUP INCOption to Purchase Common StockD Disposition to Issuer	Group Executive Vice President	DDisposition to Issuer	−11.7K sh	—	—	0
2004-10-20	INVERESK RESEARCH GROUP INCOption to Purchase Common StockD Disposition to Issuer	Group Executive Vice President	DDisposition to Issuer	−262 sh	—	—	0
2004-04-23	INVERESK RESEARCH GROUP INCS Sale	Group Executive Vice President	SSale	−9,950 sh	$30.17	−$300K	165,663
2004-04-23	INVERESK RESEARCH GROUP INCOption to purchase common stockM Exercise/Conversion	Group Executive Vice President	MExercise/Conversion	−9,950 sh	$30.17	−$300K	262
2004-04-20	INVERESK RESEARCH GROUP INCS Sale	Group Executive Vice President	SSale	−50 sh	$30.17	−$1,508.5	165,663
2004-04-20	INVERESK RESEARCH GROUP INCOption to purchase common stockM Exercise/Conversion	Group Executive Vice President	MExercise/Conversion	−50 sh	$30.17	−$1,508.5	10,212
2004-04-19	INVERESK RESEARCH GROUP INCS Sale	Group Executive Vice President	SSale	−23.6K sh	$29.27	−$690K	165,663
2004-04-19	INVERESK RESEARCH GROUP INCOption to purchase common stockM Exercise/Conversion	Group Executive Vice President	MExercise/Conversion	−23.6K sh	$29.27	−$690K	10,262
2003-11-25	INVERESK RESEARCH GROUP INCS Sale	Group Executive Vice President	SSale	−30K sh	$19.20	−$576K	165,663
2003-11-24	INVERESK RESEARCH GROUP INCOption to purchase common stockM Exercise/Conversion	Group Executive Vice President	MExercise/Conversion	−30K sh	$19.20	−$576K	43,844
2003-09-08	INVERESK RESEARCH GROUP INCS Sale	Group Executive Vice President	SSale	−6,000 sh	$18.90	−$113K	165,663
2003-09-08	INVERESK RESEARCH GROUP INCOption to purchase common stockM Exercise/Conversion	Group Executive Vice President	MExercise/Conversion	−6,000 sh	$18.90	−$113K	73,844

Recent filings

Accepted (ET)
Feb 44
CORNERSTONE THERAPEUTICS INC0001209191-14-006767
SEC(opens sec.gov)
Sep 174
CORNERSTONE THERAPEUTICS INC0001209191-13-044600
SEC(opens sec.gov)
Nov 84
MCEWAN ALASTAIR STUART0001209191-12-052306
SEC(opens sec.gov)
Jun 224
MCEWAN ALASTAIR STUART0001209191-09-033207
SEC(opens sec.gov)
Jun 164
MCEWAN ALASTAIR STUART0001209191-09-032392
SEC(opens sec.gov)
Jun 94
MCEWAN ALASTAIR STUART0001209191-09-031459
SEC(opens sec.gov)
Jun 14
MCEWAN ALASTAIR STUART0001209191-09-029956
SEC(opens sec.gov)
May 204
MCEWAN ALASTAIR STUART0001209191-09-027794
SEC(opens sec.gov)
Jun 54
Averion International Corp.0000897069-07-001343
SEC(opens sec.gov)
Jul 184
IT&E INTERNATIONAL GROUP0000897069-06-001705
SEC(opens sec.gov)
Dec 234
CHARLES RIVER LABORATORIES INTERNATIONAL INC0001100682-04-000102
SEC(opens sec.gov)

Companies

Address

C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250

CARY, NC, 27518